The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood–tumor and blood–brain barriers improve outcomes in a rat glioma model
Open accessAbstract
The blood-brain-barrier (BBB) prevents the transport of most anticancer agents to the central nervous system and restricts delivery to infiltrating brain tumors. The heterogeneous vascular permeability in tumor vessels, along with several other factors, creates additional barriers for drug treatment for brain tumors. Focused ultrasound (FUS), when combined with circulating microbubbles, is an emerging noninvasive method to temporarily permeabilize the BBB and the “blood-tumor barrier”. Here, we tested the impact of three weekly sessions of FUS and liposomal doxorubicin (DOX) in 9L rat glioma tumors. Animals that received FUS + DOX (N = 8) had a median survival time that was increased significantly (P < 0.001) compared to animals who received DOX only (N = 6), FUS only (N = 8), or no treatment (N = 7). Median survival for animals that received FUS + DOX was increased by 100% relative to untreated controls, whereas animals who received DOX alone had only a 16% improvement. Animals who received only FUS showed no improvement. No tumor cells were found in histology in 4/8 animals in the FUS + DOX group, and in two animals, only a few tumor cells were detected. Adverse events in the treatment group included skin toxicity, impaired activity, damage to surrounding brain tissue, and tissue loss at the tumor site. In one animal, intratumoral hemorrhage was observed. These events are largely consistent with known side effects of doxorubicin and with an extensive tumor burden. Overall this work demonstrates that multiple sessions using this FUS technique to enhance the delivery of liposomal doxorubicin has a pronounced therapeutic effect in this rat glioma model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Multiple significance tests: the Bonferroni method
Bland, J. M., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.310.6973.170 · Cited by 3,341
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
Hynynen, K., McDannold, N., Vykhodtseva, N., & Jolesz, F. A. (2001) · Radiology · doi:10.1148/radiol.2202001804 · Cited by 1,456
Self-citationPardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604318103 · Cited by 645
Self-citationSheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 617
Self-citationMcDannold, N., Arvanitis, C. D., Vykhodtseva, N., & Livingstone, M. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0128 · Cited by 588
Self-citationTumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584
McDannold, N., Clement, G. T., Black, P., Jolesz, F., & Hynynen, K. (2010) · Neurosurgery · doi:10.1227/01.neu.0000360379.95800.2f · Cited by 555
Self-citationTreat, L. H., McDannold, N., Vykhodtseva, N., Zhang, Y., Tam, K., & Hynynen, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22732 · Cited by 545
Self-citationUziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
McDannold, N., Vykhodtseva, N., & Hynynen, K. (2006) · Physics in Medicine and Biology · doi:10.1088/0031-9155/51/4/003 · Cited by 447
Self-citationChemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Barth, R. F., & Kaur, B. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9875-7 · Cited by 427
Drug and Gene Delivery to the Brain
Pardridge, W. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01054-1 · Cited by 405
O’Reilly, M. A., & Hynynen, K. (2012) · Radiology · doi:10.1148/radiol.11111417 · Cited by 401
Liu, H.-L., Hua, M.-Y., Yang, H.-W., Huang, C.-Y., Chu, P.-C., Wu, J.-S., Tseng, I.-C., Wang, J.-J., Yen, T.-C., Chen, P.-Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003388107 · Cited by 395
Liu, H.-L., Hua, M.-Y., Chen, P.-Y., Chu, P.-C., Pan, C.-H., Yang, H.-W., Huang, C.-Y., Wang, J.-J., Yen, T.-C., & Wei, K.-C. (2010) · Radiology · doi:10.1148/radiol.10090699 · Cited by 393
Jordão, J. F., Ayala-Grosso, C. A., Markham, K., Huang, Y., Chopra, R., McLaurin, J., Hynynen, K., & Aubert, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010549 · Cited by 378
Brain tumor survival: Results from the National Cancer Data Base
Surawicz, T. S., Davis, F., Freels, S., Laws, E. R., & Menck, H. R. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1006091608586 · Cited by 345
Minniti, G., Amelio, D., Amichetti, M., Salvati, M., Muni, R., Bozzao, A., Lanzetta, G., Scarpino, S., Arcella, A., & Enrici, R. M. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.08.020 · Cited by 323
McDannold, N., Vykhodtseva, N., Raymond, S., Jolesz, F. A., & Hynynen, K. (2005) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2005.07.010 · Cited by 323
Self-citationTreat, L. H., McDannold, N., Zhang, Y., Vykhodtseva, N., & Hynynen, K. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.04.015 · Cited by 296
Self-citationDoxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
Kievit, F. M., Wang, F. Y., Fang, C., Mok, H., Wang, K., Silber, J. R., Ellenbogen, R. G., & Zhang, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.024 · Cited by 289
Tung, Y.-S., Vlachos, F., Choi, J. J., Deffieux, T., Selert, K., & Konofagou, E. E. (2010) · Physics in Medicine and Biology · doi:10.1088/0031-9155/55/20/007 · Cited by 245
Siegal, T., Horowitz, A., & Gabizon, A. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.6.1029 · Cited by 232
Park, E.-J., Zhang, Y.-Z., Vykhodtseva, N., & McDannold, N. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.007 · Cited by 223
Self-citationPark, J., Zhang, Y., Vykhodtseva, N., Jolesz, F. A., & McDannold, N. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.012 · Cited by 217
Self-citationRadiographic patterns of relapse in glioblastoma
Chamberlain, M. C. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0251-4 · Cited by 215
Walter, K. A., Tamargo, R. J., Olivi, A., Burger, P. C., & Brem, H. (1995) · Neurosurgery · doi:10.1227/00006123-199512000-00013 · Cited by 206
Geers, B., Lentacker, I., Sanders, N. N., Demeester, J., Meairs, S., & De Smedt, S. C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.024 · Cited by 159
Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment
Chen, P., Liu, H.-L., Hua, M. Y., Yang, H., Huang, C.-Y., Chu, P.-C., Lyu, L.-A., Tseng, I.-C., Feng, L.-Y., Tsai, H., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq054 · Cited by 139
Neuwelt, E. A., Glasberg, M. R., Frenkel, E. P., & Barnett, P. A. (1983) · Annals of Neurology · doi:10.1002/ana.410140310 · Cited by 133
Mei, J., Cheng, Y. Z., Song, Y., Yang, Y., Wang, F., Liu, Y., & Wang, Z. (2009) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2009.28.7.871 · Cited by 122
Ananda, S., Nowak, A. K., Cher, L., Dowling, A., Brown, C., Simes, J., & Rosenthal, M. A. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.02.026 · Cited by 116
Brigger, I., Morizet, J., Laudani, L., Aubert, G., Appel, M., Velasco, V., Terrier-Lacombe, M.-J., Desmaële, D., d’Angelo, J., Couvreur, P., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.019 · Cited by 101
Yang, F., Yang, F., & Wang (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29229 · Cited by 87
Intratumoral Doxorubicin in Patients With Malignant Brain Gliomas
Voulgaris, S., Partheni, M., Karamouzis, M. V., Dimopoulos, P., Papadakis, N., & Kalofonos, H. P. (2002) · American Journal of Clinical Oncology · doi:10.1097/00000421-200202000-00013 · Cited by 84
Mechanism of Low-Frequency Ultrasound in Opening Blood–Tumor Barrier by Tight Junction
Shang, X., Wang, P., Liu, Y., Zhang, Z., & Xue, Y. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9451-9 · Cited by 83
Doxorubicin-induced cell death in highly invasive human gliomas.
Stan, A. C., Casares, S. A., Radu, D., Walter, G. F., & Brumeanu, T. (1999) · PubMed · Cited by 81
Zhou, R., Mazurchuk, R., & Straubinger, R. M. (2002) · PubMed · Cited by 71
Arnold, R. D., Mager, D. E., Slack, J. E., & Straubinger, R. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1365 · Cited by 69
Uptake of Adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas
von Holst, H., Knochenhauer, E., Blomgren, H., Collins, V. P., Ehn, L., Lindquist, M., Norén, G., & Peterson, C. (1990) · Acta Neurochirurgica · doi:10.1007/bf01842886 · Cited by 62
Hekmatara, T., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Matschke, J., Gelperina, S. E., Kreuter, J., & Glatzel, M. (2009) · Clinical Neuropathology · doi:10.5414/npp28153 · Cited by 61
Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles
Wohlfart, S., Khalansky, A. S., Bernreuther, C., Michaelis, M., Cinatl, J. J., Glatzel, M., & Kreuter, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.046 · Cited by 47
Cited by
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Mainprize, T., Lipsman, N., Huang, Y., Meng, Y., Bethune, A., Ironside, S., Heyn, C., Alkins, R., Trudeau, M., Sahgal, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36340-0 · Cited by 618
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 605
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Metadata
- Authors
- Aryal, M., Vykhodtseva, N., Zhang, Y.-Z., Park, J., & McDannold, N.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 169
- Issue
- 1-2
- Pages
- 103-111
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1964956174
- Cited by
- 261
- References
- 45
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.